| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |